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  Healing of skin wound is a multi-factorial and complex process. Proper treatment of diabetic 
wounds is still a major clinical challenge. Although diabetes mellitus can occur in ruminants, 
healing of wounds in diabetic ruminants has not yet been investigated. The aim of this study 
was to evaluate healing of ovine excisional diabetic wound model. Eight 4-month-old Iranian 
Makoui wethers were equally divided to diabetic and nondiabetic groups. Alloxan monohydrate 
(60 mg kg-1, IV) was used for diabetes induction. In each wether, an excisional wound was 
created on the dorsum of the animal. Photographs were taken in distinct times for planimetric 
evaluation.  Wound  samples  were  taken  on  day  21  post-wounding  for  histopathologic 
evaluations of epidermal thickness, number of fibroblasts and number of new blood vessels. 
The planimetric study showed slightly delay in wound closure of diabetic animals, however, it 
was not significantly different from nondiabetic wounds (p ≥ 0.05). Furthermore, epidermal 
thickness,  number  of  fibroblasts  and  number  of  blood  vessels  were  significantly  lower  in 
diabetic group (p < 0.05). We concluded that healing of excisional diabetic wounds in sheep may 
be compromised, as seen in other species. However, contraction rate of these wounds may not 
be delayed due to metabolic features of ruminants and these animals might go under surgeries 
without any serious concern. However, healing quality of these wounds may be lower than 
normal wounds. 
© 2013 Urmia University. All rights reserved. 
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׌ژولوتاپوتس׌ه و ׌رتم׌نلاپ هعلاطم :ناس֩ولآ اب هدش اقلا ֩׌تبا׌د نادنفسوگ رد ׌تشادرب مخز ما׌تلا  
 هد׌֩چ  
مخز نامرد .تسا هد׌ֆ׌پ و ׌لماعدنֆ دن׌ارف ֩׌ تسوپ مخز ما׌تلا ׌م سوت׌لم تبا׌د هֆر֯ .تسا هدمع ׌ن׌لاب ل֩شم ֩׌ نانֆمه ֩׌تبا׌د ׌اه ه ،دهد خر نا֯دنن֩راوخشن رد دناوت  ما׌تلا زون
مخز .تسا دنفسو֯ ֩׌تبا׌د مخز لدم ما׌تلا ׌با׌زرا هعلاطم ن׌ا فده .تسا هتفر֯ن رارق ׌با׌زرا دروم ֩׌تبا׌د نا֯دنن֩راوخشن ׌اه    دادعت تشه   سأر    رن هرب  ׀تخا  ׌׌و֩ام 4    ود هب ׌واسم روط هب ههام
وم ناس֩ولآ زا تبا׌د ׌اقلا ׌ارب .دندش م׌سقت ֩׌تبا׌در׌غ و ֩׌تبا׌د هور֯ ( تارد׌هون 06   ׌ل׌م مر֯    رب  داج׌ا ناو׌ح تشپ ه׌حان رد ׌تشادرب مخز ֩׌ هرب ره رد .دش هدافتسا )׌د׌رو لخاد ،مر֯ول׌֩
 ׌با׌زرا ׌ارب .دش ׌رتم׌نلاپ   نامز رد  زور رد .د׌در֯ ماجنا ׌رادربس֩ع صخشم ׌اه 12   هنومن ،مخز داج׌ا زا سپ ماخض رظن زا ֩׌֘ولوتاپوتس׌ه ׌با׌زرا ׌ارب مزلا ׌اه تسلابورب׌ف دادعت ،مرد׌پا ت  و اه
.دش هتفر֯ د׌دج ׌نوخ قورع دادعت    ׌با׌زرا  ׌رتم׌نلاپ ت ׌֩دنا أ هتسب رد ر׌خ مخز ما׌تلا تعرس اب نآ توافت دنֆره ،داد ناشن ار ֩׌تبا׌د تاناو׌ح مخز ندش ׌نعم ֩׌تبا׌در׌غ ׌اه ( دوبن راد 60 / 6 p ≥ .)  
،ن׌ا رب نوزفا   تسلابورب׌ف دادعت ،مرد׌پا تماخض دادعت و اه   هب ֩׌تبا׌در׌غ هور֯ رد ׌نوخ قورع ׌نعم تروص ( دوب ֩׌تبا׌د هور֯ زا رتش׌ب ׌راد 60 / 6 p < .)   داد ناشن هعلاطم ن׌ا ج׌اتن   مخز ما׌تلا ه֩  ׌اه
هنو֯ ر֯׌د دننامه تسا ن֩مم دنفسو֯ رد ֩׌تبا׌د  .دوش ل֩شم راֆد اه هֆر֯ا هتسب تعرس تسا ن֩مم ، مخز ن׌ا ندش ׌֯֘׌و ل׌لد هب اه ت راֆد نا֯دنن֩راوخشن ׌֩׌لوباتم ׌اه أ  ن׌اربانب و ،دوشن ر׌خ
 د׌اش  ناوتب تاناو׌ح ن׌ا   ׌دج ׌نار֯ن نودب ار   داد رارق ׌حارج دروم ؛   دنֆره  ، مخز ن׌نֆ ما׌تلا ت׌ف׌֩ تسا ن֩مم مخز زا رتم֩ ׌׌اه .دشاب ׌ع׌بط ׌اه  
:׌د׌ل֩ ׌اه هژاو    ،ناس֩ولآ ،ما׌تلا   ،تسوپ   دنفسو֯ ،֩׌تبا׌د مخز    
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Introduction 
 
Healing of skin wound is a multi-factorial and complex 
process.1 This process is mainly divided into inflammatory, 
proliferative, and remodeling phases.2 In the proliferative 
phase,  re-epithelialization,  angiogenesis,  and  granulation 
occur, and endothelial cells, fibroblasts, and keratinocytes 
are  mainly  involved.3  Re-epithelialization  is  one  of  the 
earliest  and  most  important  stages  of  wound  healing 
mediated by keratinocytes.4 Angiogenesis, or the process 
of forming new blood vessels, is critical to wound healing 
because it allows the delivery of vital cells and nutrients to 
the  wound,5 and is  induced  by  many angiogenic  factors 
releasing from fibroblasts and macrophages.6 Fibroblasts 
not only are responsible for collagen synthesis, but also play 
an important role in wound contraction by differentiation 
to myofibroblasts. They also excrete various growth factors 
and  cytokines  involved  in  the  wound  healing  such  as 
keratinocyte  growth  factor  (KGF),  vascular  endothelial 
growth factor (VEGF) and transforming growth factor (TGF).7 
Treatment  of  chronic  wounds,  especially  in  diabetic 
patients, is a major clinical challenge.8 Diabetes mellitus is 
a disorder of carbohydrate, lipid and protein metabolism 
that  can  affect  many  organs,  including  skin.9  The  full 
mechanisms  of  impaired  wound  healing  in  diabetes 
mellitus have not yet been demonstrated.10 Nonetheless, 
increased  inflammation,  disordered  extracellular  matrix 
synthesis and remodeling, and re-epithelialization problems 
are evident in these wounds.8 On the other hand, the effect 
of  diabetes  on  the  wound  healing  is  the  impairment  of 
cellular  proliferation  for  most  cell  types.11  Furthermore, 
micro-  and  macro-angiopathy,  and  retardation  of 
granulation tissue formation may also be present.12 It is 
suggested that cellular and molecular signals that normally 
encourage wound healing do not exist in diabetic wounds, 
and this is the major factor of delayed healing.13 
Several  researchers  investigate  healing  problems  of 
diabetic  wounds  in  various  species  such  as  human,  rat, 
mouse, rabbit, and pig.13-18 Although diabetes develops in 
sheep,19  differences  between  diabetic  and  nondiabetic 
wound healing of this species have not yet been evaluated. 
The aim of this study was to evaluate healing characteristics 
of ovine excisional diabetic wound model. 
 
Materials and Methods 
 
Animals. All experimental procedures were approved 
by the Advisory Committee of Urmia University Research 
Council. Eight 4-month-old Iranian Makoui wethers (average 
body weight 25 ± 1.5 kg at arrival) were used in this study. 
The overall health of the wethers was monitored before 
and throughout the study. The animals were kept in barn 
and  received  antibiotic  and  anti-parasitic  medications 
prior to study and were acclimatized to the experimental 
conditions for 14 days. Body weight of the animals was 
  recorded at arrival and at end of the study. The animals 
had free access to hay and tap water throughout the study. 
Wool of the animals was clipped a week before surgery. 
Ear tags were used after local infiltrative anesthesia by 1 mL 
of lidocaine HCl 1% solution (Shahid Ghazi Pharmaceutical 
Co., Tabriz, Iran). The animals were randomly divided into 
two experimental groups (n = 4). One group was considered 
nondiabetic  (ND)  and  did  not  receive  any  diabetogenic 
material and in diabetic (D) group, diabetes was induced 
by alloxan monohydrate (Sigma Aldrich Co., Dorset, UK). 
Blood glucose and serum insulin assays. To ensure 
diabetes induction and maintenance, venous blood samples 
were taken in the fasted state from external jugular vein 
three weeks before alloxan injection and throughout the 
study weekly. Blood glucose levels were determined using 
glucometer  device (On-Call  Plus; ACON Biotech Co. Ltd., 
Hangzho,  Zhejiang,  China).  Serum  insulin  values  were 
measured using ovine insulin ELISA kit (ALPCO Diagnostics, 
Salem, NH, USA). 
Diabetic  conscious  sheep  model.  In  the  diabetic 
group, 10% solution of alloxan monohydrate was infused 
at a dose of 45 mg kg-1 into external jugular vein, after 
24 hr of fasting, similar to procedure performed in dogs.20 
Alloxan  was  injected  immediately  after  dissolving  in 
normal saline solution because of its very short half-life in 
saline and blood. None of the wethers developed diabetes 
on following two weeks, and another infusion of alloxan at 
a dose of 60 mg kg-1 was performed. Diabetes induction 
was confirmed a week later.  
Surgical  wound  model.  Two  weeks  after  diabetes 
induction, dorsum of the sheep were shaved and under local 
anesthesia and aseptic preparation, a square measuring of 
2×2 cm was outlined in each animal using a marker. Then, 
the demarcated areas of skin were removed by scalpel. The 
wounds were left undressed after hemostasis. Systemic and 
topical antibiotics were used to prevent infection for 5 days.  
Planimetry. Photographs were taken immediately after 
wounding and on days 3, 7, 10, 14, and 21 post-operation 
by a digital camera while a ruler was placed near the wounds 
(Fig.  1).  The  wound  areas  were  analyzed  by  Measuring 
Tool of Adobe Acrobat 9 Pro Extended software (Adobe 
Systems Inc,  San  Jose,  CA, USA) and  wound contraction 
percentage was calculated using the following formula: 
Percentage of wound contraction = (A0 – At) / A0 × 100 
where A0 is the original wound area and At is the wound 
area at the time of imaging.21 
Histopathologic analysis. Tissue biopsies were taken 
under local anesthesia for histopathologic evaluations on 
day 21 post-operation. The specimens were fixed in 10% 
buffered formalin solution, dehydrated in alcohol, cleared 
in xylene and embedded in paraffin. Five μm thick sections 
were cut and stained with hematoxylin and eosin (H&E). 
The  slides  were  assessed  under  light  microscope  for 
epidermal thickness, number of fibroblasts, and number of 
new blood vessels.  151 
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The thicknesses of the epidermal areas formed were 
measured in ten different places along the wound surface 
by using a graticule eyepiece lens and the average of these 
areas were taken as the thickness of the epidermis. The 
number of newly formed blood vessels and fibroblasts in 
H&E  stained  sections  were  counted  by  special  morpho-
metric lens in 0.25 mm2 microscopic field. Ten different 
areas in the sections were counted and mean values were 
taken into account. 
Statistical  analysis.  All  experimental  results  were 
presented as mean ± standard deviation (SD). Differences 
were considered significant at p < 0.05. Planimetric data were 
analyzed  with  repeated  measures  analysis  of  variance 
(ANOVA) using SAS Proc Mixed (Version 9.2, SAS Institute 
Inc., Cary, NC, USA). The models included the fixed effects 
of group, treatment, day and their interactions and also a 
random  effect  associated  with  the  sheep  nested  within 
group.  The models were compared using likelihood ratio 
test statistic. The correlation structure between the repeated 
measures over time were examined by including SP (POW), 
SP (GAU), and SP (SPH) to the model and the appropriate 
covariant structure was selected based on the lowest value 
of Akaike information criterion (AIC) statistic. After fitting the 
model,  assumptions of normal distribution,  equal variance 
and unusual observations were checked using the residuals. 
If a significant fixed effect was detected, differences between 
least squares means were compared using the Bonferroni 
test. Insulin and glucose concentrations were analyzed by 
one-way  ANOVA  and  Tukey’s  test  to  assess  statistical 
differences between experimental groups, and histopatho-
logic parameters were analyzed by Student’s t-test. 
 
Results 
 
Table  1  shows  blood  glucose  and  serum  insulin 
concentrations in the wethers before and after induction 
of  diabetes.  The  results  showed  significant  increase  in 
glucose and decrease in insulin concentrations in diabetic 
group  after  administration  of  alloxan  monohydrate  and 
confirmed induction of diabetes (p < 0.05). The effect of 
diabetes on body weight of the animals is shown in Table 2. 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Wound contraction percentage in different groups over 
time series is shown in figure 2. Although healing rate of 
diabetic  wounds  were  slightly  lower  than  nondiabetic 
wounds after day 7, there was not any significant difference 
between  diabetic  and  nondiabetic  wound  contraction 
percentages  (p  ≥  0.05).  However,  the  figure  shows  that 
time  has  significant  effect  on  wound  contraction  of  all 
wounds (p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Wound contraction percentage (Mean ± SD) in different time 
points compared to first day of wounding. 
ABC different capital letters indicate significant differences (p < 0.05) 
in wounds of diabetic sheep in different time points.  
abcd Different minuscule letters indicate significant differences 
(p < 0.05) in wounds of nondiabetic  sheep in different time points. 
 
Table 1. Concentration (Mean ± SD) of serum insulin and blood 
glucose before and after injection of alloxan monohydrate. 
  Nondiabetic  Diabetic  
(pre-diabetic) 
Diabetic  
(post-diabetic) 
Insulin (µIU mL-1)  13.19 ± 1.13a  12.34 ± 1.14a  2.08 ± 1.10b 
Glucose (mg dL-1)  61.83 ± 7.03a  64.41 ± 9.85a  199.41 ± 56.97b 
ab Means in the each row followed by the same letter are not 
significantly different (p ≥ 0.05). 
Fig. 1. Serial photographs of wounds in diabetic (D) and nondiabetic (ND) sheep in different days. 
Table 2. Body weight of animals (Mean ± SD) recorded at arrival 
and end of the study. 
  Arrival (kg)  End of the Study (kg) 
Nondiabetic  24.50 ± 2.08  27.00 ± 2.58 
Diabetic  25.25 ± 1.25  21.75 ± 2.62 
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The  histopathologic  parameters  including  epidermal 
thickness, fibroblast count and number of new blood vessels 
are expressed in figures 3, 4, and 5, respectively. All of these 
parameters in diabetic group were significantly lower than 
those of nondiabetic group (p < 0.05). Not only epidermis 
was thicker in nondiabetic group (Figs. 6A and 6B), but also 
fibroblast proliferation and collagen synthesis in this group 
were more than those of diabetic group (Figs. 6C and 6D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  3.  Epidermal  thickness  (μm)  of  diabetic  and  nondiabetic 
wounds (Mean ± SD). Asterisk (*) indicates significant difference 
(p < 0.05) between diabetic and nondiabetic wounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Number of fibroblasts per 0.25 mm2 (Mean ± SD). Asterisk 
(*) indicates significant  difference (p < 0.05) between diabetic 
and nondiabetic wounds. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Number of new blood vessels per 0.25 mm2 (Mean ± SD). 
Asterisk (*) indicates significant difference (p  < 0.05) between 
diabetic and nondiabetic wounds. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  6.  Experimental  Wounds,  A)  Diabetic  group.  Regenerated 
epidermis with loose texture regenerated tissue (H&E, 100×). B) 
Nondiabetic  group.  Growing  epidermis  with  the  underlying 
granulation tissue (H&E, 100×). C) Diabetic group. Repaired area 
with  fibroblasts  showing  loose  texture  (H&E,  400×).  D) 
Nondiabetic  group.  Dense  fibroblastic  proliferation  with  blood 
vessels and collagen fibers (H & E, 400×). 
 
Discussion 
 
We studied wound healing characteristics of alloxan-
induced diabetes in sheep. Although diabetes develops in 
sheep,19 to the best of our knowledge, healing characteristics 
of excisional diabetic wound in ovine model has not been 
documented. The results of this study revealed impairment 
of  wound  healing  process  in  diabetic  sheep  model  by 
planimetric and histopathologic evaluations.  
Currently, the diabetic animal models used in researches 
include  normoglycemic,  oral  glucose  loading,  chemical 
induction with streptozotocin or alloxan, and surgical diabetic 
models. Alloxan is the second most commonly used chemical 
for induction of diabetes mellitus.22 Alloxan exerts specific, 
irreversible  effects  on  β-cells  of  pancreas  leading  to 
complete inhibition of pro-insulin biosynthesis.23 With this 
agent, it is possible to produce different grades of severity 
of  the  disease  by  varying  the  dose  of  alloxan  used.22  
Reportedly, injection of alloxan to sheep at the dose of 
28 mg kg-1 has the success rate of 45.00% and mortality 
rate of 15.00%.19 In a similar study, only one of three ewes 
injected  with  alloxan  at  a  dose  of  50  mg  kg-1  showed 
diabetes.24 Another study showed diabetes developing in all 
sheep at a dose of 45 mg kg-1 and mortality rate of 2.50%.25 
No specific cause for such loss in alloxan-induced diabetic 
model has been documented, and this resistance may be 
also seen in other species such as rabbits.26 153 
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Although diabetes can develop in sheep a day after intra-
venous injection,24 in our experience, the dose of 45 mg kg-1 
of  alloxan  was  not  effective  on  two-week  follow-up. 
However, after injection of alloxan at a dose of 60 mg kg-1, 
all of the sheep became diabetic and none of them died 
during the study. Alloxan is metabolized very rapidly in 
the body and its half-life is less than 1 min.27 This fact rules 
out the cumulative effect of first and second alloxan doses 
in model animals. Insulin plays a crucial role in the control 
of  glucose  metabolism.  This  hormone  enhances  glucose 
consumption in muscle and adipose tissues and stimulates 
phosphorylation of glucose and synthesis of glycogen in 
the liver.28 Although vast range of plasma insulin varying 
from 10 to 50 μU mL-1 has been reported in sheep,29 and 
the  exact  amount  of hypoinsulinemia  indicating  diabetes 
has not been documented in this species as well. Our data 
showed apparent decrease of serum insulin level a week 
after alloxan injection and we were convinced about diabetes 
development. Distinct concurrent hyperglycemia also con-
firmed this situation. The high concentration of glucose in 
the wound environment promotes glycation and abnormal 
binding of proteins that lead to the formation of advanced 
glycation  end-product  (AGE)  and  oxygen  free  radicals. 
Free radicals disrupt the redox balance, damaging the DNA, 
and lead to poor healing.18 Body weight of the diabetic group 
was  decreased  during  the  study,  but  nondiabetic  group 
showed slightly increase in body weight. The rationale for 
this difference may be affection of carbohydrate, protein, 
and fat metabolism with insulin deficiency. Thus, muscle 
tissue  undergoes  catabolic  metabolism  for  energy,  and 
protein synthesis is inhibited, resulting in muscle wasting.30 
Healing of diabetic wounds in many species are relatively 
delayed compared with nondiabetic wounds due to vascular, 
neuropathic, immune, and biochemical abnormalities and 
are associated with high blood glucose levels.31-33  In the 
present  study,  wound  contraction  of  nondiabetic group 
reached to 84.25 ±  3.77%, while diabetic  group  showed 
only 77.75 ± 7.76% of contraction in 21st day of wounding. 
Nevertheless, this difference was not significant (p ≥ 0.05). 
There are many metabolic differences between ruminants 
and other species. For instance, volatile fatty acid (VFA), 
and  not  glucose,  is  major  source  of  energy  for  these 
animals,  and  only  small  amount  of  glucose  is  absorbed 
from the digestive tract of ruminants. Furthermore, insulin 
regulation of ruminants is less dependent on glucose.28,34,35 
Thus,  sheep  are  less  responsive  to  insulin  than  non-
ruminants,36  and  our  finding  may  be  related  to  these 
differences.  Since  high  blood  glucose  level  is  the  major 
factor affecting wound healing in diabetes,37 it is presumed 
that wound healing in diabetic ruminants may not greatly 
affect  because  of  their  lower  concentration  of  blood 
glucose, even in diabetic state. However, for complete and 
correct understanding of exact roles of these parameters, 
there is a need to do more studies with further samples. 
Again, our histopathologic findings showed that angio- 
genesis,  re-epithelialization,  and  fibroblast  population  of 
excisional  diabetic  wounds  are  significantly  lower  than 
those of normal wounds. The fewer fibroblast population 
in  the  wound,  the  fewer  produced  collagen  fibers.7  Our 
findings  also  revealed  lower  density  of  collagen  fibers 
along with their more irregular pattern in diabetic group 
than that of nondiabetic group. It means quality of healing 
is  compromised  and  proliferative  phase  of  healing  is 
delayed  in  such  wounds,  despite  nearly  normal  rate  of 
wound closure. Migration of fibroblasts to the wound bed 
during healing process leads to granulation tissue formation 
and angiogenesis. Therefore, oxygen and necessary nutrients 
for the healing process reach readily to the wound. Some 
of  the  fibroblasts  also  differentiate  into  myofibroblasts, 
which  will  help  in  contraction  of  the  wound  edges.38 
Granulation tissue formation allows migration of epithelial 
cells  across  the  new  tissue  and  the  re-epithelialization 
takes  place.2,23  Considering  these  important  features  of 
fibroblast and angiogenesis, we can presume wounds with 
more angiogenesis and fibroblast proliferation may heal 
better than others. Protease concentration is increased in 
diabetic wounds. These enzymes degrade tissue proteins 
and interrupt new extra-cellular matrix (ECM) formation. 
The defective scaffold with lower concentration of collagen 
and protein diminishes cell proliferation stimulation. On 
the  other  hand,  in  proliferative  phase,  the  activity  of 
fibroblasts is reduced and the migration of keratinocytes is 
impaired.18  In  diabetic  wounds,  inflammatory  phase  of 
healing is pro-longed, synthesis and organization of collagen 
is impaired,39 angiogenesis is decreased,40 and formation of 
mature granulation tissue is delayed.41 In normal wound 
healing, endothelial cells of granulation tissue and epithelial 
cells undergo apoptosis in late phase of healing. Signals of 
apoptosis are also involved in the collagen degradation by 
inducing  collagenase  activity  and  decreasing  fibroblast 
numbers. But in diabetic  wounds apoptosis  is increased 
throughout the healing process.37 This fact supports our 
histopathologic  findings.  Wound  healing  process  can  be 
divided  into  primary  and  secondary  intentions.  Healing 
with  second  intention  process  takes  much  longer  time 
than  primary  intention,  despite  the  similarity  of  these 
processes.42  The  results  of  this  study  showed  adverse 
effect of diabetes on second intention wound healing of 
sheep. Therefore, for further evaluation of diabetes effect 
on wound healing in ruminants, incisional wound model 
with primary intention healing process may be required. 
In conclusion, healing of excisional diabetic wounds in 
sheep  may  be  compromised,  as  seen  in  other  species. 
However, the contraction rate of these wounds may not be 
delayed due to metabolic features of ruminants and these 
animals  might  go  under  surgeries  without  any  serious 
concern. Nevertheless, more animals involvement in such 
studies as well as considering longer time period between 
diabetes induction and wounding, and using other wound 
models such as incisional wounds are proposed. 154 
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